Lakefront Biotherapeutics NV (GLPG) Form 6-K — Jun 30, 2026
Lakefront Biotherapeutics NV repurchased 83,530 of its own ordinary shares between June 22 and June 26, 2026, at an average price of €25.24 per share, spending a total of €2,108,045.52. The repurchases were executed on Euronext Amsterdam (XAMS) as part of a buyback program announced on June 9, 2026. Following these transactions, Lakefront holds 199,734 of its own ordinary shares as of June 26, 2026. The company continues to execute its previously announced capital return program.
Key figures
- Shares Outstanding
- 199734
- Exchange
- XAMS
- Lowest Price Eur
- 24.38
- Average Price Eur
- 25.24
- Highest Price Eur
- 25.82
- Repurchase Period
- 2026-06-22 to 2026-06-26
- Shares Repurchased
- 83530
- Shares Held As Of Date
- 2026-06-26
- Repurchase Program Announced Date
- 2026-06-09
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.